Skip to Content
You are currently on the new version of our website. Access the old version .

2,721 Results Found

  • Review
  • Open Access
53 Citations
7,129 Views
14 Pages

Mutational Landscape and Environmental Effects in Bladder Cancer

  • Takuji Hayashi,
  • Kazutoshi Fujita,
  • Yujiro Hayashi,
  • Koji Hatano and ,
  • Atsunari Kawashima,
  • David J. McConkey and
  • Norio Nonomura
  • + 2 authors+ 0 author

23 August 2020

Bladder cancer is the most common cancer of the urinary tract. Although nonmuscle-invasive bladder cancers have a good prognosis, muscle-invasive bladder cancers promote metastases and have a poor prognosis. Comprehensive analyses using RNA sequence...

(This article belongs to the Special Issue The Effect of Dietary Factors on Cancer 2.0)
  • Article
  • Open Access
6 Citations
3,956 Views
17 Pages

Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer

  • Sarah Förster,
  • Maryam Givehchi,
  • Katja Nitschke,
  • Thomas Mayr and ,
  • Kerstin Kilian,
  • Samikshan Dutta,
  • Kaustubh Datta,
  • Philipp Nuhn,
  • Zoran Popovic and
  • Philipp Erben
  • + 6 authors+ 1 author

9 April 2021

Urothelial bladder cancer ranks among the 10 most frequently diagnosed cancers worldwide. In our previous study, the transmembrane protein neuropilin-2 (NRP2) emerged as a predictive marker in patients with bladder cancer. NRP2 consists of several sp...

(This article belongs to the Special Issue Genetics and Genomics of Bladder Cancer)
  • Review
  • Open Access
33 Citations
4,172 Views
14 Pages

The Sirenic Links between Diabetes, Obesity, and Bladder Cancer

  • Emily Gill,
  • Gurimaan Sandhu,
  • Douglas G. Ward,
  • Claire M. Perks and
  • Richard T. Bryan

15 October 2021

There is considerable evidence of a positive association between the incidence of type 2 diabetes mellitus (T2DM) and obesity with bladder cancer (BCa), with the link between T2DM and obesity having already been established. There also appear to be p...

(This article belongs to the Special Issue The Role of the IGF Axis in Disease 2.0)
  • Article
  • Open Access
37 Citations
5,939 Views
16 Pages

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer

  • Sophie Wucherpfennig,
  • Michael Rose,
  • Angela Maurer,
  • Maria Angela Cassataro and ,
  • Lancelot Seillier,
  • Ronja Morsch,
  • Ehab Hammad,
  • Philipp Heinrich Baldia,
  • Thorsten H. Ecke and
  • Nadine T. Gaisa
  • + 7 authors+ 2 authors

26 October 2021

Histologically, bladder cancer is a heterogeneous group comprising urothelial carcinoma (UC), squamous cell carcinoma, adenocarcinomas (ACs), urachal carcinomas (UrCs), and small cell neuroendocrine carcinomas (SCCs). However, all bladder cancers hav...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
784 Views
6 Pages

Clinical Utility of Bladder Cancer Biomarkers

  • Laura Maria Krabbe,
  • Georgios Gakis and
  • Yair Lotan

13 October 2020

Each year, there are an estimated 550 000 diagnoses of bladder cancer worldwide, and almost 200 000 deaths from bladder cancer. The need for frequent follow-up, including invasive procedures like cystoscopy, repetitive procedures like transurethral r...

  • Review
  • Open Access
908 Citations
39,214 Views
12 Pages

Epidemiology of Bladder Cancer

  • Kalyan Saginala,
  • Adam Barsouk,
  • John Sukumar Aluru,
  • Prashanth Rawla and ,
  • Sandeep Anand Padala and
  • Alexander Barsouk
  • + 1 author+ 0 author

13 March 2020

Based on the latest GLOBOCAN data, bladder cancer accounts for 3% of global cancer diagnoses and is especially prevalent in the developed world. In the United States, bladder cancer is the sixth most incident neoplasm. A total of 90% of bladder cance...

(This article belongs to the Section Cancer and Cancer-Related Research)
  • Review
  • Open Access
9 Citations
3,310 Views
20 Pages

30 October 2025

The human bladder hosts a resident, low-biomass microbial community (urobiota) that has only become the subject of intense investigation in the last 15 years. The advantages that the urobiota may confer to the bladder, in contrast to the microbiota o...

(This article belongs to the Special Issue Microbiomes in Human Health and Disease)
  • Article
  • Open Access
6 Citations
3,072 Views
19 Pages

Development of a Bladder Cancer-on-a-Chip Model to Assess Bladder Cancer Cell Invasiveness

  • Desiree J. Ewell,
  • Nita Vue,
  • Sakib M. Moinuddin,
  • Tanoy Sarkar and ,
  • Fakhrul Ahsan and
  • Ruth L. Vinall
  • + 1 author+ 0 author

26 July 2024

We have developed a bladder cancer-on-a-chip model which supports the 3D growth of cells and can be used to assess and quantify bladder cancer cell invasiveness in a physiologically appropriate environment. Three bladder cancer cell lines (T24, J82,...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
52 Citations
8,937 Views
24 Pages

Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers

  • Gabriela Vanessa Flores Monar,
  • Thomas Reynolds,
  • Maxie Gordon,
  • David Moon and
  • Chulso Moon

21 September 2023

Bladder cancer is one of the most financially burdensome cancers globally, from its diagnostic to its terminal stages. The impact it imposes on patients and the medical community is substantial, exacerbated by the absence of disease-specific characte...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Review
  • Open Access
36 Citations
11,552 Views
14 Pages

Bladder cancer is a significant public health concern and social burden due to its high recurrence risk. Intravesical drug instillation is the primary therapy for bladder cancer to prevent recurrence. However, the intravesical drug therapeutic effect...

  • Review
  • Open Access
22 Citations
6,069 Views
19 Pages

Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder

  • Vincent Sauzeau,
  • Julien Beignet and
  • Christian Bailly

Bladder pathologies, very common in the aged population, have a considerable negative impact on quality of life. Novel targets are needed to design drugs and combinations to treat diseases such as overactive bladder and bladder cancers. A promising n...

(This article belongs to the Special Issue The Role of Inflammatory Cytokines in Cancer Progression)
  • Review
  • Open Access
6 Citations
6,601 Views
18 Pages

RETRACTED: Animal Models in Bladder Cancer

  • Traian Constantin,
  • Mihai Păvălean,
  • Ștefana Bucur,
  • Maria Magdalena Constantin and ,
  • Alin Codruț Nicolescu,
  • Irina Pacu and
  • Victor Mădan
  • + 2 authors+ 0 author

24 November 2021

Background: Bladder cancer (urothelial cancer of the bladder) is the most common malignancy affecting the urinary system with an increasing incidence and mortality. Mouse models of bladder cancer should possess a high value of reproducibility, predic...

(This article belongs to the Special Issue Biomarkers and New Therapeutical Strategies for Cancer Diagnosis and Treatment)
  • Proceeding Paper
  • Open Access
2,930 Views
8 Pages

Bladder Cancer and Fluorescence Cystoscopy

  • Maria Przygoda and
  • David Aebisher

Bladder cancer is one of the ten most common types of cancer diagnosed in the world. During this time, an unbalanced state of reactive oxygen species’ (ROS) production and antioxidant capacity occurs that causes oxidative damage, cell damage, a...

(This article belongs to the Proceedings of The 2nd International Electronic Conference on Nutrients)
  • Review
  • Open Access
10 Citations
13,037 Views
54 Pages

Bladder Cancer Basic Study and Current Clinical Trials

  • Dominik Godlewski,
  • Sara Czech,
  • Dorota Bartusik-Aebisher and
  • David Aebisher

22 September 2024

Bladder cancer (BCa) is the fourth most common cancer in men and one of the most common urinary tract cancers, especially in developed countries. The aim of this paper is to comprehensively analyze the biology of bladder cancer, including its epidemi...

  • Review
  • Open Access
9 Citations
4,922 Views
15 Pages

Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer

  • Jillian Marie Walker,
  • Padraic O’Malley and
  • Mei He

23 September 2022

Muscle Invasive Bladder Cancer (MIBC) is a subset of bladder cancer with a significant risk for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A diagnostic work-up for MIBC is inclusive of urologic evaluation, radiograp...

(This article belongs to the Special Issue Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine)
  • Review
  • Open Access
78 Citations
26,706 Views
22 Pages

Imaging and Management of Bladder Cancer

  • Vincenzo K. Wong,
  • Dhakshinamoorthy Ganeshan,
  • Corey T. Jensen and
  • Catherine E. Devine

19 March 2021

Methods: Keyword searches of Medline, PubMed, and the Cochrane Library for manuscripts published in English, and searches of references cited in selected articles to identify additional relevant papers. Abstracts sponsored by various societies includ...

  • Review
  • Open Access
30 Citations
8,486 Views
17 Pages

The Urinary Microbiome and Bladder Cancer

  • Nassib Abou Heidar,
  • Tariq A. Bhat,
  • Usma Shabir and
  • Ahmed A. Hussein

17 March 2023

Bladder cancer is the 10th most common cancer worldwide. Approximately 75% of patients with bladder cancer will present with non-muscle invasive disease. Patients are usually treated with transurethral resection of bladder tumor (TURBT), in addition...

(This article belongs to the Special Issue Urinary Microbiome and Genitourinary System Disorders)
  • Article
  • Open Access
12 Citations
4,924 Views
14 Pages

Genomic Landscape of Young-Onset Bladder Cancer and Its Prognostic Implications on Adult Bladder Cancer

  • Sun-Wha Im,
  • Chang Ohk Sung,
  • Kun Suk Kim,
  • Nam Hoon Cho and ,
  • Young Min Kim,
  • Ghee Young Kwon,
  • Kyung Chul Moon,
  • Song-Yi Choi,
  • Jae Sung Lim and
  • Yong Mee Cho
  • + 18 authors+ 13 authors

28 January 2020

Due to the rare occurrence of young-onset bladder cancer (YBC), its genomic characteristics remain largely unknown. Twenty-nine biopsy-proven YBC cases were collected using a nation-wide search for bladder cancer diagnosed at 20 years or younger. Who...

(This article belongs to the Special Issue Pathogenesis and Diagnosis of Genitourinary Cancer)
  • Review
  • Open Access
35 Citations
5,923 Views
8 Pages

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer

  • Arthur Peyrottes,
  • Idir Ouzaid,
  • Gianluigi Califano,
  • Jean-Francois Hermieu and
  • Evanguelos Xylinas

29 July 2021

Background and Objectives: Facing neoadjuvant chemotherapy followed by surgery, neoadjuvant immunotherapy is an innovative concept in localized muscle-invasive bladder cancer. Herein, we performed a review of the available and ongoing evidence suppor...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
1 Citations
3,564 Views
8 Pages

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review

  • Roberto Contieri,
  • Renate Pichler,
  • Francesco del Giudice,
  • Gautier Marcq and ,
  • Andrea Gallioli,
  • Simone Albisinni,
  • Francesco Soria,
  • David d’Andrea,
  • Wojciech Krajewski and
  • Laura S. Mertens
  • + 10 authors+ 5 authors

30 April 2024

Background: Follow-up after radical cystectomy (RC) for bladder cancer can be divided into oncological and functional surveillance. It remains unclear how follow-up after RC should ideally be scheduled. The aim of this report was to gain insight into...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
11 Citations
10,209 Views
15 Pages

Squamous Cell Bladder Cancer: A Rare Histological Variant with a Demand for Modern Cancer Therapeutics

  • Scott D. Bell,
  • Anthony E. Quinn,
  • Alfred Bajo,
  • Trenton G. Mayberry and ,
  • Braydon C. Cowan,
  • Austin J. Marrah,
  • Mark R. Wakefield and
  • Yujiang Fang
  • + 3 authors+ 0 author

7 January 2025

Bladder cancer is among the most common form of cancer worldwide and is predicted to increase in incidence and mortality over the next decade. Squamous cell carcinoma of the bladder is a rare histological variant typically associated with schistosomi...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
19 Citations
1,281 Views
12 Pages

Conservative Treatment of Invasive Bladder Cancer

  • N. J. Rene,
  • F. B. Cury and
  • Luis Souhami

1 August 2009

The concept of organ-preserving therapies is a trend in modern oncology, and several tumour types are now treated in this fashion. Trimodality therapy consisting of as thorough a transurethral resection of the bladder tumour as is judged safe, follow...

  • Review
  • Open Access
10 Citations
4,578 Views
14 Pages

Bladder Cancer and Probiotics: What Do We Know So Far?

  • Pedro Sánchez-Pellicer,
  • Claudia Boix-Rodríguez,
  • Adriana Hernández-Belmonte,
  • Cristina de la Encarnación-Castellano and ,
  • Alberto Mendiola-López,
  • Eva Núñez-Delegido,
  • Laura Navarro-Moratalla,
  • Juan Agüera-Santos,
  • Vicente Navarro-López and
  • Juan Antonio Galán-Llopis
  • + 5 authors+ 0 author

23 November 2023

Bladder cancer is around the 10th most diagnosed cancer, although has a considerable mortality. Recent research and new methodologies have discarded the historical dogma that the bladder (and urine) was sterile under normal conditions. Specifically,...

(This article belongs to the Special Issue Advances in Bacteria and Cancer)
  • Review
  • Open Access
36 Citations
6,649 Views
13 Pages

Advanced Bladder Cancer: Changing the Treatment Landscape

  • Vladimir Bilim,
  • Hiroo Kuroki,
  • Yuko Shirono,
  • Masaki Murata and ,
  • Kaede Hiruma and
  • Yoshihiko Tomita
  • + 1 author+ 0 author

20 October 2022

Bladder cancer is the 10th most common cancer type in the world. There were more than 573,000 new cases of bladder cancer in 2020. It is the 13th most common cause of cancer death with an estimated more than 212,000 deaths worldwide. Low-grade non-mu...

(This article belongs to the Section Mechanisms of Diseases)
  • Review
  • Open Access
10 Citations
4,592 Views
22 Pages

RNA-Binding Proteins in Bladder Cancer

  • Yuanhui Gao,
  • Hui Cao,
  • Denggao Huang,
  • Linlin Zheng and ,
  • Zhenyu Nie and
  • Shufang Zhang
  • + 1 author+ 0 author

10 February 2023

RNA-binding proteins (RBPs) are key regulators of transcription and translation, with highly dynamic spatio-temporal regulation. They are usually involved in the regulation of RNA splicing, polyadenylation, and mRNA stability and mediate processes su...

(This article belongs to the Special Issue The Role and Therapeutic Target Potential of RBPs in Cancer)
  • Review
  • Open Access
15 Citations
4,187 Views
12 Pages

CD44 in Bladder Cancer

  • Jason Duex and
  • Dan Theodorescu

18 March 2024

The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a r...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
7 Citations
3,622 Views
10 Pages

Bladder Cancer during Pregnancy: A Review of the Literature

  • Angelis Peteinaris,
  • Paraskevas Perros,
  • Ioannis Prokopakis,
  • Zacharias Fasoulakis and ,
  • Thomas Ntounis,
  • Konstantinos Daglas,
  • Ira Eirini Kostopoulou,
  • Athina A. Samara,
  • Konstantinos Pagonis and
  • Antonios Koutras
  • + 14 authors+ 9 authors

21 September 2023

Bladder malignancy represents the fourth most common cancer in men and the eighth in women in the western world. Women under 75 years of age have a risk of 0.5–1% of developing bladder cancer. The diagnosis usually occurs between 65 and 70 year...

(This article belongs to the Section Methodology, Drug and Device Discovery)
  • Article
  • Open Access
3 Citations
2,685 Views
13 Pages

Use of Bladder-Related Medication in Non-Muscle Invasive Bladder Cancer Patients

  • Linea Blichert-Refsgaard,
  • Charlotte Graugaard-Jensen,
  • Mette Nørgaard and
  • Jørgen Bjerggaard Jensen

20 May 2024

Repeated transurethral bladder resections (TURBs) and instillation treatments in non-muscle invasive bladder cancer (NMIBC) might influence bladder function and, therefore, quality of life. Bladder-related medication is a surrogate marker of compromi...

(This article belongs to the Special Issue Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II))
  • Review
  • Open Access
52 Citations
8,694 Views
14 Pages

27 March 2017

Most bladder tumors have complex genomes characterized by a high mutation burden as well as frequent copy number alterations and chromosomal rearrangements. Alterations in DNA repair pathways—including the double-strand break (DSB) and nucleotide exc...

(This article belongs to the Special Issue DNA Repair Pathways in Cancer)
  • Article
  • Open Access
8 Citations
2,526 Views
11 Pages

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

  • Takeo Tatsuta,
  • Jun Ito,
  • Koji Yamamoto,
  • Shigeki Sugawara and ,
  • Masahiro Hosono,
  • Makoto Sato and
  • Taeko Miyagi
  • + 2 authors+ 0 author

Bladder cancer is the 10th most commonly diagnosed cancer worldwide. The current standard treatment for advanced bladder cancer is neoadjuvant cisplatin (NAC)-based chemotherapy followed by cystectomy. However, the response rate to chemotherapy is on...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
21 Citations
5,035 Views
15 Pages

Bacteria for Treatment: Microbiome in Bladder Cancer

  • Kyungchan Min,
  • Hyun Tae Kim,
  • Eun Hye Lee,
  • Hansoo Park and
  • Yun-Sok Ha

The human body contains a variety of microbes. The distribution of microbes varies from organ to organ. Sequencing and bioinformatics techniques have revolutionized microbial research. Although previously considered to be sterile, the urinary bladder...

(This article belongs to the Special Issue Advances in Urothelial Cancer)
  • Article
  • Open Access
11 Citations
5,301 Views
20 Pages

How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients

  • Andreja Erman,
  • Urška Kamenšek,
  • Urška Dragin Jerman,
  • Mojca Pavlin and ,
  • Maja Čemažar,
  • Peter Veranič and
  • Rok Romih
  • + 2 authors+ 0 author

Non-muscle-invasive bladder cancer is the most common form of bladder cancer. The main problem in managing bladder tumors is the high recurrence after the transurethral resection of bladder tumors (TURBT). Our study aimed to examine the fate of intra...

(This article belongs to the Special Issue Bladder Cancer)
  • Article
  • Open Access
1 Citations
2,433 Views
11 Pages

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?

  • Ryunosuke Nakagawa,
  • Kouji Izumi,
  • Renato Naito,
  • Suguru Kadomoto and ,
  • Hiroaki Iwamoto,
  • Hiroshi Yaegashi,
  • Shohei Kawaguchi,
  • Takahiro Nohara,
  • Kazuyoshi Shigehara and
  • Atsushi Mizokami
  • + 7 authors+ 2 authors

23 November 2022

Background: Inchworm sign is considered to be a characteristic finding in non-muscle invasive bladder cancer (NMIBC). Nevertheless, pathologically diagnosed muscle invasive bladder cancers (MIBCs) are occasionally diagnosed from tissue obtained by tr...

(This article belongs to the Special Issue Urologic Cancer: Endoscopic, Laparoscopic, and Robot-Assisted Surgery Management)
  • Review
  • Open Access
10 Citations
6,433 Views
24 Pages

Novel Strategies and Therapeutic Advances for Bladder Cancer

  • Matthew I. Ehrlich,
  • Robert D. Fox,
  • Karie D. Runcie,
  • Mark N. Stein and
  • Alexander Z. Wei

20 June 2025

Background/Objectives: To summarize the relevant trials relating to novel strategies and therapeutic advances in the treatment of bladder cancer. Methods: A comprehensive review of the literature and recent/ongoing clinical trials was conducted, focu...

(This article belongs to the Section Cancer Therapy)
  • Proceeding Paper
  • Open Access
3 Citations
2,184 Views
6 Pages

Electronic Nose for Bladder Cancer Detection

  • Heena Tyagi,
  • Emma Daulton,
  • Ayman S. Bannaga,
  • Ramesh P. Arasaradnam and
  • James A. Covington

This study outlines the use of an electronic nose as a method for the detection of VOCs as biomarkers of bladder cancer. Here, an AlphaMOS FOX 4000 electronic nose was used for the analysis of urine samples from 15 bladder cancer and 41 non-cancerous...

(This article belongs to the Proceedings of The 1st International Electronic Conference on Chemical Sensors and Analytical Chemistry)
  • Review
  • Open Access
8 Citations
4,511 Views
14 Pages

The Role of Maximal TURBT in Muscle-Invasive Bladder Cancer: Balancing Benefits in Bladder Preservation and Beyond

  • Farshad Sheybaee Moghaddam,
  • Sami Dwabe,
  • Nataliya Mar,
  • Leila Safdari and ,
  • Navin Sabharwal,
  • Hanan Goldberg,
  • Michael Daneshvar and
  • Arash Rezazadeh Kalebasty
  • + 3 authors+ 0 author

30 September 2024

Radical cystectomy with lymph node dissection and urinary diversion is the gold-standard treatment for non-metastatic muscle-invasive bladder cancer (MIBC). However, in patients who refuse cystectomy, or in whom cystectomy carries a high risk, bladde...

(This article belongs to the Section Cancer Therapy)
  • Protocol
  • Open Access
1 Citations
2,903 Views
6 Pages

Analysis of Multi-Cavity (Bladder, Intestinal and Vaginal) Microbiome in Bladder Cancer Patients: Protocol for a Systematic Review

  • Marie Semmler,
  • Uwe Bieri,
  • Andres Affentranger,
  • Dominik Enderlin and ,
  • Luca Truscello,
  • Thomas Scherer,
  • Silvan Sigg,
  • Ernest Kaufmann,
  • Michael Scharl and
  • Cédric Poyet
  • + 6 authors+ 1 author

1 July 2022

The overall pathogenesis of bladder cancer is still unknown. The microbiota has been shown to play a critical role in the development of different types of cancer. Nevertheless, the role of the microbiota in the development of bladder cancer is still...

  • Article
  • Open Access
5 Citations
3,203 Views
10 Pages

Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study

  • Sara Monteiro-Reis,
  • João P. S. Ferreira,
  • Ricardo A. Pires,
  • João Lobo and ,
  • João A. Carvalho,
  • Rui L. Reis,
  • Renato Natal Jorge and
  • Carmen Jerónimo
  • + 3 authors+ 0 author

5 January 2023

Bladder cancer (BlCa), specifically urothelial carcinomas, is a heterogeneous disease that derives from the urothelial lining. Two main classes of BlCa are acknowledged: the non-muscle invasive BlCa and the muscle-invasive BlCa; the latter constituti...

(This article belongs to the Special Issue New Advances in Urothelial Cancer: Diagnosis, Therapy and Prognosis)
  • Review
  • Open Access
18 Citations
4,283 Views
16 Pages

New Approaches to Targeting Epigenetic Regulation in Bladder Cancer

  • Daryl Thompson,
  • Nathan Lawrentschuk and
  • Damien Bolton

20 March 2023

Epigenetics is a growing field and in bladder cancer, it is of particular interest in advanced or metastatic disease. As opposed to genetic mutations in which the nucleotide sequence itself is altered, epigenetic alterations refer to changes to the g...

(This article belongs to the Topic Novel Approaches in Bladder Cancer Treatment)
  • Article
  • Open Access
4 Citations
3,890 Views
20 Pages

The Role of FGFR3 in the Progression of Bladder Cancer

  • Sahoko Ninomiya,
  • Yukari Ishiguro,
  • Hisashi Hasumi,
  • Ryosuke Jikuya and ,
  • Akihito Hashizume,
  • Masanobu Yamazaki,
  • Jun-ichi Teranishi,
  • Kazuhide Makiyama,
  • Hiroji Uemura and
  • Takashi Kawahara
  • + 6 authors+ 1 author

6 November 2025

Introduction: Bladder cancer is associated with a high recurrence rate, and outcomes for muscle-invasive and metastatic disease remain poor. New targeted therapies, such as the FGFR inhibitor erdafitinib, have been introduced, but the progression fro...

(This article belongs to the Special Issue New Insights into General, Functional and Oncologic Urology)
  • Review
  • Open Access
29 Citations
7,041 Views
23 Pages

Commensal microbes have increasingly been found to be involved in the development and progression of cancer. The recent discovery of the urinary microbiome bolstered the notion that microbes might play a role in bladder cancer. Although microbial inv...

(This article belongs to the Special Issue Microbiome in Urological Diseases)
  • Article
  • Open Access
8 Citations
2,747 Views
9 Pages

Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer

  • Takahito Kawano,
  • Yoko Tachibana,
  • Junichi Inokuchi,
  • Jeong-Hun Kang and ,
  • Masaharu Murata and
  • Masatoshi Eto
  • + 1 author+ 0 author

27 August 2021

Bladder cancer has a high recurrence rate; therefore, frequent and effective monitoring is essential for disease management. Cystoscopy is considered the gold standard for the diagnosis and continuous monitoring of bladder cancer. However, cystoscopy...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
22 Citations
6,455 Views
26 Pages

Nanomedicine in Bladder Cancer Therapy

  • Adrianna Winnicka,
  • Joanna Brzeszczyńska,
  • Joanna Saluk and
  • Paulina Wigner-Jeziorska

26 September 2024

Bladder cancer (BC) is one of the most common malignant neoplasms of the genitourinary system. Traditional BC therapies include chemotherapy, targeted therapy, and immunotherapy. However, limitations such as lack of specificity, cytotoxicity, and mul...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
1 Citations
1,690 Views
19 Pages

Desmocollin-3 and Bladder Cancer

  • Chandreshwar P. Shukla,
  • Nayan K. Jain,
  • Michael A. O’Donnell,
  • Kapil V. Vachhani and ,
  • Rashmi Patel,
  • Janki Patel,
  • Rajiv Modi,
  • Arpit Dheeraj,
  • Jee Min Lee and
  • Bakulesh Khamar
  • + 7 authors+ 2 authors

23 April 2025

Background: Desmocollin3, a transmembrane protein, is expressed in the basal/suprabasal layer of normal stratified epithelium. DSC3 gene expression is described in muscle-invasive bladder cancer (MIBC). DSC3-protein-expressing recurrent non-muscle-in...

  • Article
  • Open Access
23 Citations
7,255 Views
14 Pages

Connexin 26 is Down-Regulated by KDM5B in the Progression of Bladder Cancer

  • Xin Li,
  • Yongping Su,
  • Jinhong Pan,
  • Zhansong Zhou and ,
  • Bo Song,
  • Enqing Xiong and
  • Zhiwen Chen
  • + 2 authors+ 0 author

11 April 2013

Connexin 26 (Cx26) expression is down-regulated and KDM5B (H3K4 demethylase) is up-regulated in the progression of bladder cancer, suggesting that Cx26 expression may be down-regulated by KDM5B in bladder cancer. To test the hypothesis, the HT1376 an...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
66 Citations
12,051 Views
12 Pages

Background: Urothelial bladder carcinoma (UBC) is the most frequent histologic form of bladder cancer, constituting 90% of the cases. It is important to know the risk factors of UBC to avoid them and to decrease its recurrence after treatment. The ai...

  • Review
  • Open Access
23 Citations
5,375 Views
20 Pages

Strategies for Overcoming Immune Evasion in Bladder Cancer

  • Juhyun Shin,
  • Jeong Won Park,
  • Seon Young Kim,
  • Jun Ho Lee and ,
  • Wahn Soo Choi and
  • Hyuk Soon Kim
  • + 1 author+ 0 author

Tumors intricately shape a highly immunosuppressive microenvironment, hampering effective antitumor immune responses through diverse mechanisms. Consequently, achieving optimal efficacy in cancer immunotherapy necessitates the reorganization of the t...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
23 Citations
6,743 Views
10 Pages

Urinary Cell-Free DNA in Bladder Cancer Detection

  • Ryan Tsz-Hei Tse,
  • Hongda Zhao,
  • Christine Yim-Ping Wong,
  • Carol Ka-Lo Cheng and ,
  • Angel Wing-Yan Kong,
  • Qiang Peng,
  • Peter Ka-Fung Chiu,
  • Chi-Fai Ng and
  • Jeremy Yuen-Chun Teoh
  • + 4 authors+ 0 author

14 February 2021

Urinary bladder cancer is a common urological cancer. Although flexible cystoscopy is widely employed in bladder cancer detection, it is expensive, invasive, and uncomfortable to the patients. Recently, urinary cell-free DNA (ucfDNA) isolated from ur...

(This article belongs to the Special Issue Early Detection, Diagnosis, and Management of Bladder Cancer – Importance of Biomarkers)
  • Review
  • Open Access
8 Citations
8,273 Views
24 Pages

Microdevices for Non-Invasive Detection of Bladder Cancer

  • Constantine Tzouanas,
  • Joey Sze Yun Lim,
  • Ya Wen,
  • Jean Paul Thiery and
  • Bee Luan Khoo

Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging a...

  • Review
  • Open Access
21 Citations
9,179 Views
14 Pages

Focus on the Use of Resveratrol in Bladder Cancer

  • Alessandro Zucchi,
  • Francesco Claps,
  • Antonio Luigi Pastore,
  • Alessandro Perotti and ,
  • Andrea Biagini,
  • Luana Sallicandro,
  • Rosaria Gentile,
  • Concetta Caglioti,
  • Federico Palazzetti and
  • Bernard Fioretti
  • + 5 authors+ 0 author

26 February 2023

Bladder cancer is the most common tumor of the urinary system, with a high incidence in the male population. Surgery and intravesical instillations can eradicate it, although recurrences are very common, with possible progression. For this reason, ad...

(This article belongs to the Section Bioactives and Nutraceuticals)

of 55